â– LECTURE OVERVIEW: Pharmacokinetics defines how the body handles a xenobiotic, focusing on the concentration-dependent kinetics of drug elimination.
â– KINETIC MECHANISMS:
1. First-Order Kinetics (Normal/Dominant):
- Definition: The rate of drug elimination is directly proportional to the plasma concentration of the drug.
- Half-Life Model: The drug exhibits a constant half-life (t1/2), meaning a constant fraction of the drug is eliminated per unit of time.
- Clearence Stability: Clearance is constant. Most clinical therapeutic agents obey first-order elimination across standard therapeutic ranges.
2. Zero-Order Kinetics (Saturation Kinetics):
- Definition: The rate of drug elimination is completely independent of plasma drug concentration. A constant amount of drug is eliminated per unit of time.
- Carrier Saturation: Occurs when the drug concentration exceeds the saturation point of metabolic enzymes or active transport clearance channels.
- Toxicity Risk: The half-life is variable (longer at higher concentrations). Continued administration easily leads to rapid, toxic drug accumulation.
â– CLINICAL COMPLICATIONS:
Delayed or incomplete treatment triggers cascading systemic strain, involving downstream organ failure, severe metabolic imbalances, or progressive tissue necrosis.
â– PHARMACODYNAMIC TARGET ENGAGEMENT:
Receptor binding dynamics dictate the overall speed, duration, and magnitude of physiological responses to therapeutic agents.
[HY-BOARD-1367]
🌟 Dynamic Clinical Key:
Three classic substances exhibit saturated, zero-order kinetics at high or therapeutic doses: Ethanol, Phenytoin (epilepsy management), and High-dose Aspirin (salicylates). In these cases, minor dosage changes can lead to disproportionately massive spikes in serum levels and severe toxicity. Early aggressive resuscitation is key to prevent irreversible multi-system organ dysfunction. Watch closely for ligand-receptor saturation effects and subsequent tolerance or resistance.